Centre Georges Francois Leclerc
Clinical trials sponsored by Centre Georges Francois Leclerc, explained in plain language.
-
Spleen radiation may offer new hope for chemo patients with dangerous low platelets
Symptom relief Not yet recruitingThis study tests a new use of targeted radiation to the spleen in 18 adults with gastrointestinal cancer who have low platelet counts and an enlarged spleen from chemotherapy. The goal is to find the safest radiation dose that can raise platelet levels and reduce bleeding risks. …
Phase: NA • Sponsor: Centre Georges Francois Leclerc • Aim: Symptom relief
Last updated May 22, 2026 13:53 UTC
-
New radiation method aims to cut dry mouth and swallowing issues in cancer patients
Symptom relief Not yet recruitingThis study tests a new way to deliver radiation for head and neck cancers that may reduce side effects like dry mouth and trouble swallowing. About 70 adults with cancer of the mouth or throat will be randomly assigned to standard or new radiation. The goal is to see if the new m…
Phase: NA • Sponsor: Centre Georges Francois Leclerc • Aim: Symptom relief
Last updated May 19, 2026 11:47 UTC
-
Blood test may predict immunotherapy success in cancer patients
Knowledge-focused Not yet recruitingThis study looks at whether tiny particles in the blood, called extracellular vesicles, can help doctors predict if immunotherapy will work for people with advanced lung cancer or melanoma. Researchers will collect blood samples from 378 patients before and during standard treatm…
Sponsor: Centre Georges Francois Leclerc • Aim: Knowledge-focused
Last updated May 26, 2026 08:33 UTC